6MR-16251-52771
4 vaccinations
1 coded response
24 check-ins
1 free-text entry
1 call case
- Sex
- Female
- Age at first dose
- 26-30
- ZIP prefix
- 070 / NJ
- Registered
- 2021-02-23
- Relationship
- Self
- Race
- White
- Ethnicity
- Not Hispanic or Latino
Timeline
-
2021-02-23
Registered in v-safe
-
2021-02-23
Dose 1 — Moderna
- 2021-02-23
-
2021-02-24
Health check-in — days 1–6 daily, dose 1Feeling: Fair · Site: Pain · Headache, Fatigue or tiredness · Be unable to do your normal daily activitiesAdult check-in
- 2021-02-25
- 2021-02-26
- 2021-02-27
- 2021-02-28
- 2021-03-01
- 2021-03-02
- 2021-03-09
- 2021-03-18
-
2021-03-23
Dose 2 — Moderna
-
2021-03-23
Health check-in — day 0, dose 2Feeling: Fair · Site: Pain · Headache, Joint pains, Fatigue or tirednessAdult check-in
-
2021-03-24
Health check-in — days 1–6 daily, dose 2Feeling: Poor · Site: Pain · Fever · Chills, Headache, Joint pains, Muscle or body aches, Fatigue or tiredness, Nausea · Be unable to work, Be unable to do your normal daily activitiesAdult check-in
-
2021-03-25
Health check-in — days 1–6 daily, dose 2Feeling: Fair · Site: Pain · Fever · Muscle or body aches, Fatigue or tiredness, NauseaAdult check-in
-
2021-03-26
Health check-in — days 1–6 daily, dose 2Feeling: Fair · Fatigue or tiredness, Nausea, Diarrhea, Abdominal painAdult check-in
- 2021-03-27
- 2021-03-30
- 2021-04-29
- 2021-05-04
-
2021-09-23
Survey response — 6 months, dose 2MedDRA: Anaphylactic reaction — Feeling: Good · Get care from a doctor or other healthcare professional · Emergency room or emergency department visit, HospitalizationFree text: Idiopathic anaphylaxis- 4 episodesMedDRA releases: 2024-11 · check-in free text available
-
2021-09-23
Report sent to call center — 6 months, dose 2Get care from a doctor or other healthcare professionalEmergency room or emergency department visit · Hospitalization · 1 call case(s)
- 2021-09-27
-
2021-12-09
Dose 3 — Moderna
-
2022-10-06
Dose 4 — Pfizer-BioNTech
- 2022-10-21
- 2022-10-27
- 2022-11-19
- 2023-01-05
- 2023-04-06
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2021-02-23 | Moderna | |
| 2 | 2021-03-23 | Moderna | |
| 3 | 2021-12-09 | Moderna | No |
| 4 | 2022-10-06 | Pfizer-BioNTech | No |
Call center
| Reported | Outcome | VAERS-related outcome |
|---|---|---|
| 2021-09-23 | Unsuccessful |
Free text
Release 9 — 6 months, dose 2
Symptoms: Idiopathic anaphylaxis- 4 episodes
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SD | Anaphylactic reaction | · | · | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release